NantKwest Announces Presentations at Upcoming Investment Conferences

CULVER CITY, Calif.--(BUSINESS WIRE)--

NantKwest, Inc (NK), a pioneering, next generation, clinical-stage immunotherapy company focused on harnessing the unique power of our immune system using natural killer (NK) cells to treat cancer, infectious diseases and inflammatory diseases, today announced that the company will be presenting at two investment conferences in September: The Rodman & Renshaw 2016 Global Healthcare Conference and the Bank of America Global Healthcare Conference.

Rodman & Renshaw 18^th Annual Global Investment Conference, September, 11-13, 2016, NYC, NY

NantKwest will be presenting and hosting one-on-one meetings at the Rodman & Renshaw 18^th Annual Global Investment Conference in New York on Monday, September 12, 2016 at the New York Palace Hotel.

Bank of America Global Healthcare Conference, September 14-17, 2016, London, UK

NantKwest will be presenting and hosting one-on-one meetings at the Bank of America Global Healthcare Conference in London on Wednesday, September 14, 2016 at the Bank of...